JP2005512949A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005512949A5 JP2005512949A5 JP2002592943A JP2002592943A JP2005512949A5 JP 2005512949 A5 JP2005512949 A5 JP 2005512949A5 JP 2002592943 A JP2002592943 A JP 2002592943A JP 2002592943 A JP2002592943 A JP 2002592943A JP 2005512949 A5 JP2005512949 A5 JP 2005512949A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor antagonist
- use according
- glucocorticoid receptor
- administration
- delirium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940126013 glucocorticoid receptor antagonist Drugs 0.000 claims 10
- 239000003850 glucocorticoid receptor antagonist Substances 0.000 claims 10
- 206010012218 Delirium Diseases 0.000 claims 7
- 208000024891 symptom Diseases 0.000 claims 7
- 230000037396 body weight Effects 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 230000003637 steroidlike Effects 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 1
- -1 dimethylaminophenyl moiety Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 claims 1
- 229960003248 mifepristone Drugs 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 150000003431 steroids Chemical group 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28861901P | 2001-05-04 | 2001-05-04 | |
| US13780002A | 2002-05-01 | 2002-05-01 | |
| PCT/US2002/014318 WO2002096433A1 (en) | 2001-05-04 | 2002-05-06 | Methods for treating delirium using glucocorticoid receptor-specific antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008313766A Division JP2009102346A (ja) | 2001-05-04 | 2008-12-09 | グルココルチコイドレセプターに特異的なアンタゴニストを使用して、せん妄を処置する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005512949A JP2005512949A (ja) | 2005-05-12 |
| JP2005512949A5 true JP2005512949A5 (https=) | 2005-12-22 |
Family
ID=26835589
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002592943A Pending JP2005512949A (ja) | 2001-05-04 | 2002-05-06 | グルココルチコイドレセプターに特異的なアンタゴニストを使用して、せん妄を処置する方法 |
| JP2008313766A Pending JP2009102346A (ja) | 2001-05-04 | 2008-12-09 | グルココルチコイドレセプターに特異的なアンタゴニストを使用して、せん妄を処置する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008313766A Pending JP2009102346A (ja) | 2001-05-04 | 2008-12-09 | グルココルチコイドレセプターに特異的なアンタゴニストを使用して、せん妄を処置する方法 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1390037B1 (https=) |
| JP (2) | JP2005512949A (https=) |
| CN (1) | CN1527713A (https=) |
| AT (1) | ATE492281T1 (https=) |
| AU (1) | AU2002303652B2 (https=) |
| CA (1) | CA2446506C (https=) |
| DE (1) | DE60238671D1 (https=) |
| IL (2) | IL158744A0 (https=) |
| NO (1) | NO334736B1 (https=) |
| NZ (1) | NZ529456A (https=) |
| WO (1) | WO2002096433A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60230936D1 (de) * | 2001-10-26 | 2009-03-05 | Organon Nv | Verwendung von (11beta, 17beta)-11-(1,3-Benzodioxol-5-yl)-17-Hydroxy-17-(1-Propinyl)-estra-4,9-dien-3-on zur Behandlung von schweren Depressionen |
| JP6053802B2 (ja) * | 2011-10-07 | 2016-12-27 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 患者を監視し、患者のせん妄を検出する監視システム |
| CN116168840B (zh) * | 2023-04-23 | 2023-12-22 | 北京大学人民医院 | 一种预测术后谵妄发生风险的方法、设备及系统 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3464012B2 (ja) * | 1993-04-05 | 2003-11-05 | 旭化成株式会社 | 精神症候治療剤 |
| IL110309A0 (en) * | 1993-07-15 | 1994-10-21 | Univ Kentucky Res Found | A method of protecting against neuron loss |
| AU747956B2 (en) * | 1997-10-06 | 2002-05-30 | Board Of Trustees Of The Leland Stanford Junior University | Methods for treating psychosis associated with glucocorticoid related dysfunction |
| IL139672A (en) * | 1998-05-15 | 2005-11-20 | Univ Leland Stanford Junior | Glucocorticoid receptor antagonists for the tretment of dementia |
| DE60232956D1 (de) * | 2001-03-23 | 2009-08-27 | Corcept Therapeutics Inc | Verfahren zur behandlung von stressbedingten erkrankungen unter verwendung von glucocorticoid-rezepto-spezifischen antagonisten |
-
2002
- 2002-05-06 WO PCT/US2002/014318 patent/WO2002096433A1/en not_active Ceased
- 2002-05-06 CA CA2446506A patent/CA2446506C/en not_active Expired - Fee Related
- 2002-05-06 EP EP02731689A patent/EP1390037B1/en not_active Expired - Lifetime
- 2002-05-06 AU AU2002303652A patent/AU2002303652B2/en not_active Ceased
- 2002-05-06 IL IL15874402A patent/IL158744A0/xx unknown
- 2002-05-06 AT AT02731689T patent/ATE492281T1/de active
- 2002-05-06 DE DE60238671T patent/DE60238671D1/de not_active Expired - Lifetime
- 2002-05-06 CN CNA028126726A patent/CN1527713A/zh active Pending
- 2002-05-06 JP JP2002592943A patent/JP2005512949A/ja active Pending
- 2002-05-06 NZ NZ529456A patent/NZ529456A/en not_active IP Right Cessation
-
2003
- 2003-11-04 NO NO20034916A patent/NO334736B1/no not_active IP Right Cessation
- 2003-11-04 IL IL158744A patent/IL158744A/en not_active IP Right Cessation
-
2008
- 2008-12-09 JP JP2008313766A patent/JP2009102346A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001518509A5 (https=) | ||
| CA2440605A1 (en) | Methods for treating stress disorders using glucocorticoid receptor-specific antagonists | |
| JP2007512371A5 (https=) | ||
| WO2006002361A3 (en) | 2-methylpropanamides and their use as pharmaceuticals | |
| WO2006020598A3 (en) | Amido compounds and their use as pharmaceuticals | |
| WO2006012227A3 (en) | Amido compounds and their use as pharmaceuticals | |
| CA2454339A1 (en) | Methods for preventing antipsychotic-induced weight gain | |
| SG151329A1 (en) | Amido compounds and their use as pharmaceuticals | |
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| SG163518A1 (en) | Amido compounds and their use as pharmaceuticals | |
| JP2005535664A5 (https=) | ||
| JP2005537268A5 (https=) | ||
| JP2010180236A5 (https=) | ||
| WO2006053024A3 (en) | Lactam compounds and their use as pharmaceuticals | |
| WO2007038138A3 (en) | Amido compounds and their use as pharmaceuticals | |
| BRPI0518281A2 (pt) | inibidores de 11-beta hidroxilesteràide desidrogenase do tipo i e mÉtodos uso dos mesmos | |
| JP2003505336A5 (https=) | ||
| JP2006508951A5 (https=) | ||
| CA2504697A1 (en) | Methods for treating migraine | |
| CA2459033A1 (en) | Methods for inhibiting cognitive deterioration in adults with down's syndrome | |
| CA2389570A1 (en) | Methods for treating mild cognitive impairment | |
| JP2005512949A5 (https=) | ||
| JP2006516651A5 (https=) | ||
| CY1108265T1 (el) | Στερεη διαστοματικη φαρμακευτικη μορφη για αντισυλληψη | |
| BR0008054A (pt) | Forma cristalina de eplerenona |